Sunday, November 23, 2025
Search Here...
HomePublications

Research and Innovation

Quick Links

Notification Center

Publications

Year 2025
  1. Shinde M, Jagadale M, Naikwade A, Mali U, Parulekar R, Gophane A, et al. Unleashing potential of methotrexate-amino acid methyl ester-loaded lipidic nanocapsules as magic bullets against resistant breast cancer. Journal of Drug Delivery Science and Technology. 2025 Feb;104:106539.
  2. Meenakshi S, Kommeri S, Prakash V, Narapaka PK, Kumar VU, Kumar O, et al. The hidden danger: the epigenetic landscape of fluoride-induced kidney damage and its role in chronic kidney disease. Environ Geochem Health. 2025 Sept;47(9):365.
  3. Suresh A, Pallaprolu N, Dande A, Pogula HK, Parihar VK, Peraman R. Temperature- and time-dependent degradation of mouse tissue proteins: insights into RNA-binding protein stability via mass spectrometry. Mol Omics. 2025;21(5):479–95.
  4. Chib S, Dutta BJ, Singh G, Singh R, Singh S. Targeting dopaminergic neuronal death: Luteolin as a therapeutic modulator in Parkinson’s disease. 3 Biotech. 2025 May;15(5):128.
  5. Berthaud V, Smith T, Amara VR, Wilus D, Nouvet FJ, Popik W. Sex-specific mitochondrial DNA changes in neuron-derived extracellular vesicles of African American adults: impact of HIV infection and smoking. J Neurovirol. 2025 Aug;31(4):389–94.
  6. Berthaud V, Smith T, Amara VR, Wilus D, Nouvet FJ, Popik W. Sex-specific mitochondrial DNA changes in neuron-derived extracellular vesicles of African American adults: impact of HIV infection and smoking. J Neurovirol. 2025 Aug;31(4):389–94.
  7. Myrsing E, Mouli HMC, Nikhil P, Deepali, Sahu A, Jana A, et al. Protein profiling uncovers IGF-1R inhibition potential of 3-(2-furoyl)-indole scaffolds in hepatocellular carcinoma. Future Medicinal Chemistry. 2025 Mar 4;17(5):513–28.
  8. Pal B, Dutta A, Chaudhary V, Kumari S, Meenakshi S, Murti K. Prevalence of antihypertensive medication adherence and associated factors in India: A systematic review and meta-analysis. Hipertensión y Riesgo Vascular. 2025 July;42(3):156–64.
  9. Boruah JLH, Gogoi M, Famhawite V, Barman D, Das DJ, Puro KN, et al. Phytochemical Characterization, Prooxidant, Antiproliferative and Anti‐Inflammatory Potential of Meyna spinosa Roxb. Ex Link Ripe Fruit. Chemistry & Biodiversity. 2025 May;22(5):e202402342.
  10. Boruah JLH, Gogoi M, Famhawite V, Barman D, Das DJ, Puro KN, et al. Phytochemical Characterization, Prooxidant, Antiproliferative and Anti‐Inflammatory Potential of Meyna spinosa Roxb. Ex Link Ripe Fruit. Chemistry & Biodiversity. 2025 May;22(5):e202402342.
  11. Rohila A, Kumar A, Sirvi PK, Dhyagala S, Kunjir S, Malayandi R. Patent Landscaping of Time-dependent Mesalamine Prolonged-release Granules: A Case Study for Generic Formulation Development. J Pharm Innov. 2025 Dec;20(6):218.
  12. Chhabra V, Swamy RS, Reddy ART, Bhushan R, Shenoy S, Maiti S, et al. Naringin alleviates fluoride-induced neurodevelopmental disorders by modulation of SIRT1, autophagy, mitochondrial fission, and ROS generation. Naunyn-Schmiedeberg’s Arch Pharmacol [Internet]. 2025 June 30 [cited 2025 Nov 12]; Available from: https://link.springer.com/10.1007/s00210-025-04398-z
  13. Kumar A, Agarwal R, Kumar K, Chayal NK, Kumar G, Kumar R, et al. Mercury poisoning in women and infants inhabiting the Gangetic plains of Bihar: risk assessment. BMC Public Health. 2025 Apr 4;25(1):1275.
  14. Pandey R, Choudhary K, Prasad SR, Kumar P, Bisht P, Aishwarya D, et al. Mechanistic and metabolic exploration of neohesperidin against lung cancer cell lines through ROS-mediated mitochondrial apoptosis: An in-silico and in-vitro approach. Toxicology and Applied Pharmacology. 2025 June;499:117350.
  15. Dande A, Pallaprolu N, Gadilohar S, Mishra S, Malayandi R, Natesan S, et al. LC-ESI-HRMS-Based Evaluation of Antioxidants as Additives to Inhibit Genotoxic Nitrosamine Formation in Metformin Hydrochloride Tablets. AAPS PharmSciTech. 2025 Aug 21;26(7):218.
  16. Agrawal A, Sikder S, Singh S, Sharma RK, Pallaprolu N, Mitra K, et al. KAT5-mediated acetylation of PC4 facilitates DNA repair by promoting chromatin reorganization. Nucleic Acids Research. 2025 Sept 23;53(18):gkaf974.
  17. Joseph A, Thencheeri SA, Malayandi R, Natesan S, Velayutham R. Investigation of Dissolution Failures of Metformin Delayed-Release Tablets During Formulation Design. Dissolut Technol. 2025;32(1):32–40.
  18. Dutta BJ, Patil VS, Gaikwad VL, Singh S. Intranasal administration of thermoresponsive pterostilbene loaded nanoemulgel confers neuroprotection in a rat model of ischemic stroke. Nanomedicine. 2025 Oct 14;1–21.
  19. Kunjir S, Pathare P, Sharma S, Deoriya J, Natesan S, Malayandi R. Influence of Milling Parameters on Crystal Morphology, Thermal Behavior, and Dissolution of Mesalamine Nanocrystals. Pharm Res. 2025 Aug;42(8):1409–27.
  20. Malgave A, Akbar S, Tiwari A, Hande S, Joseph A, Malayandi R. Influence of Buffering Capacity, pH, and Temperature on the Stability of Semaglutide: A Preformulation Study. Journal of Peptide Science. 2025 Aug;31(8):e70039.
  21. Mouli HMC, Harini D, Shaikh N, Khemchandani R, Shreya S, Jana A, et al. In silico characterization of indole-substituted densely functionalized pyrrole against breast cancer: Integrating DFT, molecular docking, MD simulations, and ADME analysis. Journal of Molecular Structure. 2025 Apr;1328:141375.
  22. Pothuraju N, Pogula HK, Jagdale R, Vadla UK, Gajbhiye RL, Parihar VK, et al. Impact of microwave-assisted acid extraction (MW-AAE) methods on simultaneous ICP-MS analysis of multi-elements in edibles besides associated greenness and human health risk assessment. Environ Monit Assess. 2025 Mar 1;197(3):344.
  23. Sarkar S, Chatterjee A, Kim D, Saritha C, Barman S, Jana B, et al. Host–Guest Adduct as a Stimuli‐Responsive Prodrug: Enzyme‐Triggered Self‐Assembly Process of a Short Peptide Within Mitochondria to Induce Cell Apoptosis. Adv Healthcare Materials. 2025 Feb;14(4):2403243.
  24. Saritha C, Rajana VK, Choudhary K, Vairagar A, Mishra A, Penumaka SM, et al. Highly selective ergosterol binding and impaired redox balance leads to improved antileishmanial efficacy for amphotericin b synthesized silver nanoparticles with reduced toxicity– In vitro and in vivo studies. Free Radical Biology and Medicine. 2025 Aug;235:405–25.
  25. Chauhan A, Kumar L, Raghavendra AP, Solomon MC, Verma R. Hesperetin for the Prevention and Treatment of Oral Cancer (A Review). Pharm Chem J. 2025 Jan;58(10):1600–9.
  26. Kumbhar S, Bhatia M, Choudhari P, Gaikwad V, Salunke M, Wakure B. Fucoxanthin Shields Vero Cells from H2O2-Induced Oxidative Damage by Potentially Activating the Nrf2 Signalling Pathway. RJPT. 2025 Mar 27;1140–6.
  27. Momin Z, D. M, B. PK, K. VB, Kumar L. Formulation, characterization, and evaluation of transdermal patches of ranolazine for chronic angina pectoris. Naunyn-Schmiedeberg’s Arch Pharmacol [Internet]. 2025 Aug 18 [cited 2025 Nov 12]; Available from: https://link.springer.com/10.1007/s00210-025-04504-1
  28. Marques SM, Salwa, Lewis CR, Devi V, Kumar L. Formulation and evaluation of HPMC and pullulan-based rapidly dissolving films containing cilnidipine nanosuspension. International Journal of Biological Macromolecules. 2025 May;310:143329.
  29. Sonule B, Khairnar Y, Mehetre N, Kumar S, Kumar L. Formulation and Characterization of Etoricoxib Suppositories for the Management of Hemorrhoids. tjps [Internet]. 2025 Jan 24 [cited 2025 Nov 12]; Available from: https://www.turkjps.org/articles/formulation-and-characterization-of-etoricoxib-suppositories-for-the-management-of-hemorrhoids/doi/tjps.galenos.2024.83583
  30. Kumar S, Khairnar Y, Karmakar A, Kumar L. Forced stability studies and estimation of encapsulated ellagic acid in nano-formulations using UV-spectroscopy. Tenside Surfactants Detergents. 2025 Jan 29;62(1):52–63.
  31. Raval H, Bhattacharya S, Bhirud D, Sangave PC, Gupta GL, Paraskar G, et al. Fabrication of lactoferrin-chitosan-etoposide nanoparticles with melatonin via carbodiimide coupling: In-vitro & in-vivo evaluation for colon cancer. Journal of Controlled Release. 2025 Jan;377:810–41.
  32. Ahuja T, Begum F, Kumar G, Shenoy S, Kumar N, Shenoy RR. Exploring the protective role of metformin and dehydrozingerone in sodium fluoride-induced neurotoxicity: evidence from prenatal rat models. 3 Biotech. 2025 Feb;15(2):36.
  33. Bhatia NM, Shekhar A, Mane P, Bhatia MS, Gaikwad VL. Exploring fatty acid-amino acid conjugate for the development of self-assembling, pH-sensitive vesicles for targeted anticancer drug delivery. Tenside Surfactants Detergents. 2025 May 26;62(3):284–96.
  34. Chaudhary V, Sharma B, Kumari S, Murti K, Meenakshi S, Pal B. Epidemiology and determinants of HIV among female sex workers in India: a systematic review and meta-analysis. Journal of HIV/AIDS & Social Services. 2025 July 3;23(3):218–38.
  35. Kendre T, Mishra R, Guha P, Rana GS, Pandey K, Dhingra S. Effect of tobacco use and nicotine dependence on the quality of sleep among tuberculosis patients: A cross-sectional study. Clinical Epidemiology and Global Health. 2025 Jan;31:101870.
  36. Sharma S, Kunjir SA, Pathare PR, Deoriya J, Sahoo A, Malayandi R. Effect of solid-state characteristics and buffers on the solubility and dissolution behaviors of mesalamine. J Therm Anal Calorim. 2025 June;150(12):9153–69.
  37. Malgave A, Akbar S, Joseph A, Dande Aishwarya, Peraman R, Malayandi R. Effect of pH, buffers, molarity, and temperature on solution state degradation of semaglutide using LC-HRMS: A preformulation protocol for peptide drug delivery. European Journal of Pharmaceutics and Biopharmaceutics. 2025 Sept;214:114780.
  38. Haldankar PP, Fernandes A, DCruz CEM, Kumar L, Shirodkar RK. Eberconazole nitrate–loaded spanlastics: nanocarriers for topical delivery system. Tenside Surfactants Detergents. 2025 Mar 26;62(2):178–99.
  39. Bheemisetty B, . S, Yarlagadda DL, Gurram P, . LK, Shenoy RR, et al. Dissolving microneedle patch incorporated with insulin nanoparticles for the management of Type-I Diabetes Mellitus: Formulation development and in vivo monitoring. Adv Pharm Bull. 2025 June 10;1.
  40. Siddiqui MA, Saraf P, Shrivastava SK, Penumaka SM, Mandal D, Saini R, et al. Discovery of platelet glycoprotein VI receptor antagonists and their neuroprotective activity: an in silico, in vitro, and in vivo study. 3 Biotech. 2025 Oct;15(10):357.
  41. Abubakar M, Giri A, Goel F, Khan M, Gupta J, Kumar D, et al. Diabetes, Alzheimer’s Disease Risk Factors, and the Cafeteria Diet: A Comprehensive Review. CN [Internet]. 2025 July 8 [cited 2025 Nov 12];23. Available from: https://www.eurekaselect.com/243446/article
  42. Mishra S, Mondal G, Kumarasamy M. Development of Low-Cost CNC-Milled PMMA Microfluidic Chips as a Prototype for Organ-on-a-Chip and Neurospheroid Applications. Organoids. 2025 June 11;4(2):13.
  43. Kunjir S, Pathare P, Sharma S, Malayandi R, Malgave A, Natesan S. Development and Validation of Particle Size Measurement for Mesalamine Nanocrystals Using Dynamic Light Scattering and Microscopic Techniques. BioNanoSci. 2025 Mar;15(1):27.
  44. Narapaka PK, Singh M, Dhingra S. Development and psychometric validation of the patient-reported involvement in shared decision-making questionnaire (PSDMQ) for healthcare systems of low- and middle-income countries (LMICs). J Public Health (Berl) [Internet]. 2025 July 17 [cited 2025 Nov 12]; Available from: https://link.springer.com/10.1007/s10389-025-02555-5
  45. Narapaka PK, Singh M, Dhingra S. Development and psychometric validation of the patient-reported involvement in shared decision-making questionnaire (PSDMQ) for healthcare systems of low- and middle-income countries (LMICs). J Public Health (Berl) [Internet]. 2025 July 17 [cited 2025 Nov 12]; Available from: https://link.springer.com/10.1007/s10389-025-02555-5
  46. Bahekar T, Meenakshi S, Narapaka PK, Kumar N, Prakash V, Murti K. Development and Psychometric Validation of Population-Based Knowledge Attitudes and Practices—Questionnaire on Fluoride (PBKAP-QF). Biol Trace Elem Res. 2025 Apr;203(4):1909–21.
  47. Kumar VU, Nikhil K, Kt MF, Shetty R, Pandey K, Kumar A, et al. Development and Psychometric Validation of Nu-KAP Questionnaire: Integrating IRT and Multigroup Factor Analysis in a Multidimensional Tool for the Assessment of Knowledge, Attitudes, and Practices of Arsenic. Biol Trace Elem Res [Internet]. 2025 Aug 2 [cited 2025 Nov 12]; Available from: https://link.springer.com/10.1007/s12011-025-04767-y
  48. Palacharla VRC, Nirogi R, Kumar N, Nandakumar K. Determination of Intrinsic Clearance and Fraction Unbound in Human Liver Microsomes and In Vitro-In Vivo Extrapolation of Human Hepatic Clearance for Marketed Central Nervous System Drugs. Eur J Drug Metab Pharmacokinet. 2025 Mar;50(2):119–35.
  49. Chaurasia U, Parvin T, Mouli HMC, Peraman R, Sahu A. Design, Synthesis and Anticancer Activity of Naphthoquinone Fused Dihydropyridine Derivatives: In Silico and In Vitro Studies. Chemistry & Biodiversity. 2025 June 13;e00417.
  50. Kesharwani A, Sree BK, Singh N, Gajbhiye RL, Murti K, Peraman R, et al. Dehydrozingerone Improves Mood and Memory in Diabetic Mice via Modulating Core Neuroimmune Genes and Their Associated Proteins. ACS Pharmacol Transl Sci. 2025 June 13;8(6):1694–710.
  51. Singh N, Kesharwani A, Sankar S H H, Gajbhiye RL, Peraman R, Bharathavikru RS, et al. Dehydrozingerone ameliorates renal structure compromised in diabetic nephropathy. Biochimica et Biophysica Acta (BBA) – Molecular Basis of Disease. 2025 Aug;1871(6):167894.
  52. Chakraborty B, Santra A, Tah D, Goswami K, Jana A, Girigoswami A, et al. Decoding the interaction of an imidazo-pyrimidine derivative with serum proteins: Spectroscopic, computational and structure-activity relationship analysis. Biophysical Chemistry. 2025 July;322:107435.
  53. Kaur SD, Abubakar M, Bedi N, Rao Puppala E, Kapoor DN, Kumar N, et al. Current perspectives on Lifileucel tumor-infiltrating lymphocyte therapy: A paradigm shift in immunotherapy. Current Problems in Cancer. 2025 Dec;59:101252.
  54. Kumar S, Kumar BH, Nayak R, Pandey S, Kumar N, Pai KSR. Computational screening and molecular dynamics of natural compounds targeting the SH2 domain of STAT3: a multitarget approach using network pharmacology. Mol Divers [Internet]. 2025 Jan 9 [cited 2025 Nov 12]; Available from: https://link.springer.com/10.1007/s11030-024-11075-5
  55. Gupta S, Maity S, Singh A, Ali A, Ali A, Dhiman S, et al. Computational Approaches for the Discovery of Novel Chromen-2-one Derivatives as 5-HT1A Inhibitors for the Treatment of Schizophrenia. J Comput Biophys Chem. 2025 Oct 8;1–30.
  56. Dhasthakeer U, Jha AN, Gupta AK. Comparison of efficacy and toxicity of chemotherapeutic regimens used as adjuvant and/or neoadjuvant chemotherapy in penile cancer patients. Current Problems in Cancer. 2025 Apr;55:101185.
  57. Kumar N, Gupta AK. Comparative Study of the Toxicity Profile in Gallbladder Cancer patients receiving Gemcitabine-Cisplatin versus Paclitaxel-Cisplatin Combination Chemotherapy. RJPT. 2025 Sept 5;4455–60.
  58. Gumudavelli SV, Shelke A, Priya P, Chauhan R, Dhingra S. Comparative efficacy and safety of tigecycline vs colistin for Carbapenem-resistant Enterobacteriaceae (CRE) infections in cancer patients. Clinical Epidemiology and Global Health. 2025 May;33:101996.
  59. Moktan N, Dey R, Pawale M, Paul T, Mukherjee S, Ghosal J, et al. Comparative assessment of biological activities and chemical profiling of different plant parts of Bergenia ciliata Haw. (Sternb). Fitoterapia. 2025 Dec;187:106877.
  60. Moktan N, Dey R, Pawale M, Paul T, Mukherjee S, Ghosal J, et al. Comparative assessment of biological activities and chemical profiling of different plant parts of Bergenia ciliata Haw. (Sternb). Fitoterapia. 2025 Dec;187:106877.
  61. Bhattacharya S, Joshi A, Beldar V, Mishra A, Sharma S, Khan R, et al. Chitosan-Coated Silver Nanourchins for Imatinib Mesylate Delivery: Biophysical Characterization, In-Silico Profiling, and Anti-Colon Cancer Efficacy. Mol Pharmaceutics. 2025 Apr 7;22(4):1983–2018.
  62. Nama L, Bhushan R, Kumar P, Arumugam S, Ranjan OP, Kumar P, et al. Chitosan nanoparticles of rutin mitigated histological changes induced in DNCB-induced colitis by enhanced modulation of inflammation and oxidative stress. J Mol Histol. 2025 Aug;56(4):200.
  63. Bhirud D, Bhattacharya S, Raval H, Sangave PC, Gupta GL, Paraskar G, et al. Chitosan nanoparticles of imatinib mesylate coated with TPGS for the treatment of colon cancer: In-vivo & in-vitro studies. Carbohydrate Polymers. 2025 Jan;348:122935.
  64. GBD 2019 Acute and Chronic Care Collaborators, Anza-Ramirez C, Miranda JJ, Armocida B, Correia JC, Van Spall HGC, et al. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019. Nat Commun. 2025 May 7;16(1):4235.
  65. Dashawant A, Khadke R, Shete A, Gaikwad V. CDSCO alerts: A retrospective dosage form – Wise analysis of quality control alerts issued to pharmaceutical companies from 2018 to 2023. Regulatory Toxicology and Pharmacology. 2025 Feb;156:105775.
  66. Kaneriya S, Jamadade P, Kumar S, Singh S. Cardio-protective effects of naringin against lipopolysaccharide-induced oxidative stress and chronic inflammation in SD rats. Comp Clin Pathol. 2024 Nov 11;34(1):55–63.
  67. Saji A, Guha P, Revathy MS, Sen A, Pandey K, Dhingra S. Bridging the gap in tuberculosis care: A mixed-methods analysis of patient safety challenges and solutions in India. Indian Journal of Tuberculosis. 2025 July;S0019570725001520.
  68. Saji A, Guha P, Revathy MS, Sen A, Pandey K, Dhingra S. Bridging the gap in tuberculosis care: A mixed-methods analysis of patient safety challenges and solutions in India. Indian Journal of Tuberculosis. 2025 July;S0019570725001520.
  69. Narsaiah C, Rathnakar B, Nimma R, Goud SSK, Sinha KK, Prasad SR, et al. Biaryl piperidine derivatives: Synthesis, antileishmanial efficacy, and molecular docking studies. IJHC. 2025 Sept;35(03):673.
  70. Obulapuram R, Narapaka PK, Esuru C, Singh M, Dhingra S. Association of GI symptoms with health-related quality of life in cancer patients undergoing chemotherapy: a prospective study. Support Care Cancer. 2025 Apr;33(4):336.
  71. Kundarapu V, Shelke A, Priya P, Mishra S, Chauhan R, Dhingra S. Assessment of surgical site infections with antimicrobial resistance among cancer patients at a tertiary care hospital: A prospective study. Clinical Epidemiology and Global Health. 2025 July;34:102103.
  72. Pund R, Vishwas G, Madhukar M, Pandey K, Dhingra S. Assessment of quality of life in visceral leishmaniasis patients coinfected with HIV: a comparative study in Bihar, India. J Health Popul Nutr. 2025 June 3;44(1):183.
  73. Gupta AK, Faruqui S, Jha AN. Assessment of periostin in postmenopausal thyroid patients: A prospective case-control study. Endocrine and Metabolic Science. 2025 Dec;19:100270.
  74. Bhosale A, Meenakshi S, Narapaka PK, Richa C, Kalaiselvan V, Dhingra S, et al. Assessment of patterns and predictors of medical device-related adverse events among oncology patients: a cross-sectional study at a tertiary care hospital. Expert Review of Medical Devices. 2025 May 4;22(5):477–87.
  75. Mahesh D, Kumar G, Gupta AK, Singh VK, Singh VD. Assessment of Obesity Indices and Cardiovascular Risk Factors in Type 2 Diabetes Mellitus: A Pilot study from a Tertiary care centre in India. RJPT. 2025 Feb 27;878–84.
  76. Wankhede H, Penumaka SM, Mandal D, Rojatkar S, Gaikwad V, Patil S. Artesunate-loaded bilosomes with enhanced oral bioavailability: in silico and in vitro study against Leishmania donovani promastigotes and in vivo pharmacokinetic assessment in rats. RSC Pharm. 2025;2(3):541–52.
  77. Chauhan A, Salwa, Shedgaonkar GG, Kumar L, Karmakar A, Khajuria S, et al. Antioxidant and anticancer activities of hesperetin and its novel formulations in KB cells. Naunyn-Schmiedeberg’s Arch Pharmacol. 2025 May;398(5):5213–36.
  78. Sharma S, Mudgal R, Krishnamurthy S, Singh S. Anticancer Activity of Fisetin via KEAP1, DNMT1, and mTOR Axis Against Colon Cancer: An Integrated In Silico, In Vitro, and In Vivo Approach. J Biochem & Molecular Tox. 2025 July;39(7):e70391.
  79. Moktan N, Gajbhiye RL, Sahithi TVVS, Roy DN, Kundu R, Banerjee A. Antibacterial and antibiofilm activities of extract and bioactive compounds from Bergenia ciliata (Haw.) Sternb. flowers against Streptococcus mutans through cell membrane damage. Journal of Ethnopharmacology. 2025 Jan;339:119144.
  80. Cheruku SP, Joisa V, Chamallamudi MR, Kumar N. Anti-tumor Efficacy of Liposomes Encapsulating Levamisole and Lipopolysaccharide in 1, 2-Dimethylhydrazine (DMH)-Induced Colon Cancer. BioNanoSci. 2025 Sept;15(3):400.
  81. Naresh P, Roy SD, Pawaskar PV, Lokhande PS, Gajbhiye RL, Peraman R. Analytical quality by design guided white analytical chemistry driven green in the development of LC-ICP-MS method for arsenic speciation analysis in HEK-293 cells. Journal of Chromatography B. 2025 Feb;1252:124474.
  82. Karmakar A, Shinde S, Yalamanda V, Khairnar Y, Nayak S, Kumar L. An AQbD-based Optimized and Green Isocratic HPLC Method for the Quantification of Simvastatin in Liposomes: Forced Degradation, Assessment of Drug Content, and Drug Entrapment. J Pharm Innov. 2025 June;20(3):95.
  83. Bhat VN, Bharati S, Bothiraja C, Sangshetti J, Gaikwad V. A review on intervention of AI in pharmaceutical sector: Revolutionizing drug discovery and manufacturing. Intelligent Pharmacy. 2025 Oct;3(5):342–9.

Year 2024

  1. Mudgal R, Singh S. Xanthine Oxidoreductase in the Pathogenesis of Endothelial Dysfunction: An Update. CHYR. 2024 Feb;20(1):10–22.
  2. Narapaka PK, Singh M, Murti K, Dhingra S. Validity and reliability of the 9-item shared decision-making questionnaire (SDM-Q-9) among Indian oncology patients in a tertiary care hospital. Clinical Epidemiology and Global Health. 2024 May;27:101626.
  3. Chavan PR, Pandey R, Patil BM, Murti K, Kumar N. Unravelling key signaling pathways for the therapeutic targeting of non-small cell lung cancer. European Journal of Pharmacology. 2025 Jul;998:177494.
  4. Vinod A, Chandra Mouli HM, Jana A, Peraman R. Unlocking therapeutic potential: exploring indole scaffolds and their structural insights as pharmacophores in designing anti-breast cancer agents. Med Chem Res. 2024 Jul;33(7):1100–32.
  5. Shinde M, Jagadale M, Naikwade A, Mali U, Parulekar R, Gophane A, et al. Unleashing potential of methotrexate-amino acid methyl ester-loaded lipidic nanocapsules as magic bullets against resistant breast cancer. Journal of Drug Delivery Science and Technology. 2025 Feb;104:106539.
  6. Jamadade P, Nupur N, Maharana KC, Singh S. Therapeutic Monoclonal Antibodies for Metabolic Disorders: Major Advancements and Future Perspectives. Curr Atheroscler Rep. 2024 Oct;26(10):549–71.
  7. Meenakshi S, Maharana KC, Nama L, Kumar Vadla U, Dhingra S, Ravichandiran V, et al. Targeting Histone 3 Variants Epigenetic Landscape and InhibitoryImmune Checkpoints: An Option for Paediatric Brain Tumours Therapy. CN. 2024 Jun;22(7):1248–70.
  8. Squire E, Lee HL, Jeong W, Lee S, Ravichandiran V, Limoli CL, et al. Targeting dysfunctional endocannabinoid signaling in a mouse model of Gulf War illness. Neuropharmacology. 2024 Dec;261:110142.
  9. Sharma S, Chakraborty M, Yadav D, Dhullap A, Singh R, Verma RK, et al. Strategic Developments in Polymer-Functionalized Liposomes for Targeted Colon Cancer Therapy: An Updated Review of Clinical Trial Data and Future Horizons. Biomacromolecules. 2024 Sep 9;25(9):5650–69.
  10. Bogadi S, Malayandi R, Vasanth Raj P, Suresh Kumar Anandasadagopan, Parvathaneni M, Kumar Kundu M, et al. Silk fibroin and sericin: Multifunctional formulations for treating diabetic wound healing. European Polymer Journal. 2024 Nov;220:113465.
  11. Devi V, Chaudhary V, Sharma M, Kumari S, Murti K, Meenakshi S, et al. Serum Levels of Heavy Metals in Patients with Prostate Cancer: A Systematic Review and Meta-analysis. Biol Trace Elem Res. 2025
  12. Sahu Y, Jamadade P, Ch Maharana K, Singh S. Role of mitochondrial homeostasis in D-galactose-induced cardiovascular ageing from bench to bedside. Mitochondrion. 2024 Sep;78:101923.
  13. Seksaria S, Dutta BJ, Kaur M, Gupta GD, Bodakhe SH, Singh A. Role of GLP-1 Receptor Agonist in Diabetic Cardio-renal Disorder: Recent Updates of Clinical and Pre-clinical Evidence. CDR. 2024 Jul
  14. Sree BK, Kumar N, Singh S. Reproductive toxicity perspectives of nanoparticles: an update. Toxicology Research 2024
  15. Goswami K, Chakraborty A, Sinha S, Jana A. Recent Advances in the Palladium‐Catalyzed Synthesis of Unnatural Tryptophans. Eur J Org Chem. 2024;27(5).
  16. Priya HK, Jha KP, Kumar N, Singh S. Reactive Oxygen Species and Mitochondrial Calcium’s Roles in the Development of Atherosclerosis. CPD. 2024 Jun;30(23):1812–21.
  17. Narapaka PK, Katikala K, Ponnala VR, Meenakshi S, Viswas G, Singh M, et al. Psychological health among healthcare professionals during COVID-19 pandemic: An updated meta-analysis. Indian Journal of Psychiatry. 2024 May;66(5):413–20.
  18. Myrsing E, Mouli HMC, Nikhil P, Deepali, Sahu A, Jana A, et al. Protein profiling uncovers IGF-1R inhibition potential of 3-(2-furoyl)-indole scaffolds in hepatocellular carcinoma. Future Medicinal Chemistry. 2025 Mar 4;17(5):513–28.
  19. Hati Boruah JL, Puro KN, Das DJ, Gogoi P, Gogoi M, Biswas A, et al. Prooxidant and anti-inflammatory potential of            Garcinia xanthochymus fruit and its phytochemical characterisation by UHPLC-Q-Orbitrap HRMS.
  20. Natural Dhir D, Kumari S, Devi V, Chaudhary V, Murti K, Dhingra S, et al. Prevalence of tobacco and alcohol use among pregnant women in India: a systematic review and meta-analysis. Journal of Substance Use. 2025 Jan;1–9.
  21. Dutta A, Chaudhary V, Gupta AK, Murti K, Kumari S, Dhir D, et al. Prevalence of depression in hypertensive patients and its associated factors in India: A systematic review and meta-analysis. Hipertensión y Riesgo Vascular. 2024 Oct;41(4):217–25.
  22. Pal B, Dutta A, Chaudhary V, Kumari S, Meenakshi S, Murti K. Prevalence of antihypertensive medication adherence and associated factors in India: A systematic review and meta-analysis. Hipertensión y Riesgo Vascular. 2024 Dec
  23. Beere V, Choudhary K, Bisht P, Rai A, Kumar N. Prediction of molecular targets for antidepressant potential of hydroalcoholic extract of Tamarindus indica using network pharmacology approach and evaluating its efficacy in Chronic Unpredictable Mild Stress model in mice. 3 Biotech. 2024 Oct.
  24. Mehta A, Makhija R, Barik P, Dhiman S, Das Gupta G, Asati V. Practical Perspectives and Roles of XRD in Drug Discovery: A Review. CAC. 2024 Aug;20(7):449–70.
  25. Bojja SL, Kolathur KK, Chaudhari BB, Hari G, Byregowda BH, Meka ST, et al. Poweromin X Ten, a polyherbal Dahat Y, Ganguly S, Khan A, Gajbhiye RL, Kumar D. Optimizing ultrasonication-assisted comprehensive extraction of bioactive flavonoids from Pterocarpus santalinus leaves using response surface methodology. Journal of Chromatography A. 2024 Dec;1738:465477.
  26. Pal B, Atem TD, Kumari S, Murti K, Kumar R, Pandey K, et al. Ophthalmic adverse effects of miltefosine in the treatment of leishmaniasis: a systematic review. Cutaneous and Ocular Toxicology. 2024 Jul 2;43(3):190–7.
  27. Dhanavath N, Bisht P, Jamadade MS, Murti K, Wal P, Kumar N. Olaparib: A Chemosensitizer for the Treatment of Jitte S, Keluth S, Bisht P, Wal P, Singh S, Murti K, et al. Obesity and Depression: Common Link and Possible Targets. CNSNDDT. 2024 Dec;23(12):1425–49.
  28. Chilamakuru NB, Vn AD, G VB, Pallaprolu N, Dande A, Nair D, et al. New synergistic benzoquinone scaffolds as inhibitors of mycobacterial cytochrome bc1 complex to treat multi-drug resistant tuberculosis. European Journal of Medicinal Chemistry. 2024 Jun;272:116479.
  29. Akhlada, Siddiqui N, Anurag, Saifi A, Kesharwani A, Parihar VK, et al. Neuroprotective Action of Selected Natural Drugs Against Neurological Diseases and Mental Disorders: Potential Use Against Radiation Damage. Neurochem Res. 2024 Sep;49(9):2336–51.
  30. Bisht P, Prasad SR, Choudhary K, Pandey R, Aishwarya D, Aravind V, et al. Naringin and temozolomide combination suppressed the growth of glioblastoma cells by promoting cell apoptosis: network pharmacology, in-vitro assays and metabolomics based study. Front Pharmacol. 2024.
  31. Samridhi, Setia A, Mehata AK, Priya V, Pradhan A, Prasanna P, et al. Nanoparticles for Thrombus Diagnosis and Therapy: Emerging Trends in Thrombus-theranostics. Nanotheranostics. 2024;8(2):127–49.
  32. Chheda D, Shete S, Tanisha T, Devrao Bahadure S, Sampathi S, Junnuthula V, et al. Multifaceted therapeutic applications of biomimetic nanovaccines. Drug Discovery Today. 2024 Jun;29(6):103991.
  33. Sharma R, Kumarasamy M, Parihar VK, Ravichandiran V, Kumar N. Monoamine Oxidase: A Potential Link in Papez Circuit to GeneralizedAnxiety Disorders. CNSNDDT. 2024 May;23(5):638–55.
  34. Kumar S, Swamy RS, Bhushan R, Chhabra V, Shenoy S, Murti K, et al. Molecular and immunohistochemical alterations in fluoride-induced neurological impediment in adult rats. Journal of Trace Elements in Medicine and Biology. 2024 Dec;86:127511.
  35. Jailani S, Pathare P, Kunjir S, Chakraborty K, Dhanapal CK, Khan NA, et al. Melt Granulation Techniques as an Alternative Manufacturing Technology for the Generic Development of Apixaban 5 mg Immediate-Release Tablets: A Case Study. J Pharm Innov. 2024 Dec;19(6).
  36. Sunny A, Varghese TP, Mary Varghese N. Knowledge, Attitude, and Dispensing Practice of Emergency ContraceptivePills among Community Pharmacists: A Cross-sectional Survey. CDTH. 2024 May;19(3):354–9.
  37. Shetty M, Shenoy S, Amuthan A, Devi V, Kumar N, Kiran A, et al. Kadukkai maathirai (Indian herbal drug) prevents hepatocellular cancer progression by enhancing GSTM1 expression and modulating β catenin transcription: in-silico and in-vivo study. F1000Res. 2024 Oct 22;13:639.
  38. Darshani P, Sarma SS, Gajbhiye RL, Srivastava AK, Kumar D. Isolation, Characterization, In Vitro and In Silico Assessment of Undescribed Bioactive Constituents from Pterocarpus santalinus Heartwood. ACS Omega. 2024 Dec 17;9(50):49013–22.
  39. Joseph A, Thencheeri SA, Malayandi R, Natesan S, Velayutham R. Investigation of Dissolution Failures of Metformin Delayed-Release Tablets During Formulation Design. Dissolut Technol. 2025;32(1):32–40.
  40. Shelke A, Priya P, Mishra S, Chauhan R, Murti K, Ravichandiran V, et al. Investigation of antimicrobial susceptibility patterns, risk factors and their impact on mortality in cancer patients at a tertiary care cancer hospital- A prospective study. Ann Clin Microbiol Antimicrob. 2024.
  41. Gaikwad VL, Sen SG, Dhake PR. Interactions between multifunctional pharmaceutical excipients and efflux pump for optimal drug transport and bioavailability: An overview. Journal of Drug Delivery Science and Technology. 2024 Apr;94:105475.
  42. Suvarna NH, Raj V, Harees S, Mathew JE, Kumar L, Verma R. Integrative Qsar Analysis Of Oxadiazole Derivatives: Resolving Molecular Determinants For Anti-Tubercular Activity And Rational Drug Design. Int J App Pharm. 2024 Sep 7;157–65.
  43. Kumar S, Arwind DA, Kumar B H, Pandey S, Nayak R, Vithalkar MP, et al. Inhibition of STAT3: A promising approach to enhancing the efficacy of chemotherapy in medulloblastoma. Translational Oncology. 2024 Aug;46:102023.
  44. Yellurkar ML, Prasanna VS, Das P, Sarkar S, Matta R, Dhaked DK, et al. Indigenous wisdom of a Kwatha to treat NASH: An insight into the mechanism. Journal of Ethnopharmacology. 2024 May;326:117935.
  45. Malayandi R, Karmakar A, Dhake P, Malgave A, Natesan S, Velayutham R. In Silico Dose Adjustment of Zolpidem in Females Using Physiologically Based Pharmacokinetic Modeling and Simulations. Sleep Vigilance. 2024 Sep 5;8(2):251–63.
  46. Mouli HMC, Harini D, Shaikh N, Khemchandani R, Shreya S, Jana A, et al. In silico characterization of indole-substituted densely functionalized pyrrole against breast cancer: Integrating DFT, molecular docking, MD simulations, and ADME analysis. Journal of Molecular Structure. 2025 Apr;1328:141375.
  47. Meenakshi S, Bahekar T, Narapaka PK, Pal B, Prakash V, Dhingra S, et al. Impact of fluorosis on molecular predictors in pathogenesis of type 2 diabetes associated microvascular complications. Journal of Trace Elements in Medicine and Biology. 2024 Dec;86:127506.
  48. Nayak KK, Birangal SR, Kumar L, Verma R. Identifying potential henr inhibitors against prostate cancer employing in silico drug repurposing approach. Int J App Pharm. 2024 Nov 7;316–28.
  49. Jain R, Aishwarya D, Wankhade S, Anupriya, Kumarasamy M, Peraman R. Identification and in vitro genotoxicity assessment of forced degradation products of glimepiride and glyburide using HEK cell‐based COMET assay. Biomedical Chromatography. 2024;38(12).
  50. Kumar P, Khan R, Singh BN, Kumari A, Rai A, Singh AK, et al. Hydroxyethylamine based analog targets microtubule assembly: an in silico study for anti-cancerous drug development. Sci Rep. 2024;14(1). Available from: https://www.nature.com/articles/s41598-024-82823-8
  51. Chauhan A, Kumar L, Raghavendra AP, Solomon MC, Verma R. Hesperetin for the Prevention and Treatment of Oral Cancer (A Review). Pharm Chem J. 2025 Jan;58(10):1600–9.
  52. Chatterjee A, Khan R, Mukherjee T, Sahoo PP, Tiwari LN, Singh BN, et al. Harnessing bacterial metabolites for enhanced cancer chemotherapy: unveiling unique therapeutic potentials. Arch Microbiol. 2024 Nov.
  53. Jagdale R, Hussain MZ, Goswami K, Peraman R, Jana A. Guanidine hydrochloride (GuHCl)-catalysed microwave-mediated solvent- and metal-free synthesis of pyrimido[1,2-a] benzimidazole from aryl aldehyde and aryl methyl ketone. Green Chem. 2024;26(16):9230–40.
  54. Cross M, Ong KL, Culbreth GT, Steinmetz JD, Cousin E, Lenox H, et al. Global, regional, and national burden of gout, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. The Lancet Rheumatology. 2024 Aug;6(8): e507–17.
  55. Ferrari AJ, Santomauro DF, Aali A, Abate YH, Abbafati C, Abbastabar H, et al. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. 2024 May;403(10440):2133–61.
  56. Naghavi M, Ong KL, Aali A, Ababneh HS, Abate YH, Abbafati C, et al. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021.
  57. Brauer M, Roth GA, Aravkin AY, Zheng P, Abate KH, Abate YH, et al. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. 2024 May;403(10440):2162–203.
  58. Schumacher AE, Kyu HH, Aali A, Abbafati C, Abbas J, Abbasgholizadeh R, et al. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. The Lancet. 2024 May;403(10440):1989–2056.
  59. Sonule B, Khairnar Y, Mehetre N, Kumar S, Kumar L. Formulation and Characterization of Etoricoxib Suppositories for the Management of Hemorrhoids. tjps. 2025.
  60. Kumar S, Khairnar Y, Karmakar A, Kumar L. Forced stability studies and estimation of encapsulated ellagic acid in nano-formulations using UV-spectroscopy. Tenside Surfactants Detergents. 2025 Jan 29;62(1):52–63.
  61. Wankhade S, Nikhil P, Jain R, Mishra S, Kumarasamy M, Ramalingam P. Forced Degradation Products of Olmesartan Medoxomil and their In Vitro Genotoxicity Assessment by Comet Assay using HEK Cells. ChemistrySelect. 2024
  62. Ahuja TN, Begum F, Beegum F, Kumar G, Kumar N, Shenoy RR. Fluoride-induced Neurodevelopmental Toxicity- AMPK as a PossibleTarget. CNSNDDT. 2025 Sep;24(9):669–84.
  63. Ahuja T, Begum F, Kumar G, Shenoy S, Kumar N, Shenoy RR. Exploring the protective role of metformin and dehydrozingerone in sodium fluoride-induced neurotoxicity: evidence from prenatal rat models. 3 Biotech. 2025
  64. Pavan G, Kumar M, Murti K, Dhingra S, Ravichandiran V. Exploring the factors influencing the health-related quality of life in patients experiencing adverse drug reactions: a cross-sectional study. J Patient Rep Outcomes
  65. Siddiqui N, Sharma A, Kesharwani A, Anurag, Parihar VK. Exploring role of natural compounds in molecular alterations associated with brain ageing: A perspective towards nutrition for ageing brain. Ageing Research Reviews. 2024 Jun;97:102282.
  66. Ali A, Chaudhary A, Sharma A, Siddiqui N, Anurag, Parihar VK. Exploring role of citrus fruits in comorbid neurodegenerative disorders associated with psoriasis. Metab Brain Dis. 2024
  67. Hussain MZ, Myrsing E, Mouli HMC, Dey K, Khajuria S, Paul AK, et al. Exploring Anticancer Potential of Furopyrano[3,4‐b] Indole via Graphene Oxide‐Catalyzed Aqueous Synthesis. ChemistrySelect. 2024 Dec ;9(48).
  68. Rao PP, Shenoy Belle V, Nayak AG, Kumar N, Rao V, Cheruku SP, et al. Evaluation of the merit of ethanolic extract of Annona reticulata as an anti-cancer agent in human colon cancer cell lines (HCT-116). F1000Res. 2024 Jun 7;12:1571.
  69. Chaudhary V, Sharma B, Kumari S, Murti K, Meenakshi S, Pal B. Epidemiology and determinants of HIV among female sex workers in India: a systematic review and meta-analysis. Journal of HIV/AIDS & Social Services. 2025 Jan 9;1–21.
  70. Mishra R, Vishwas G, Kendre T, Guha P, Murti K, Pandey K, et al. Epidemiological determinants and quality of life in PLHIV patients with tuberculosis in Bihar State, India. Indian Journal of Tuberculosis. 2024;71:S258–63.
  71. Sen S, Kumar N, Ranjan OP. Emerging nanocarriers as advanced delivery tools for the treatment of leukemia. Nanomedicine. 2025 Apr 3;20(7):725–35.
  72. Swamy R, Kumar N, Shenoy S, Kumar N, Rao V. Effect of naringin on sodium fluoride‑induced neurobehavioral deficits in Wistar rats. Biomed Rep . 2024 ;20(6).
  73. Haldankar PP, Fernandes A, DCruz CEM, Kumar L, Shirodkar RK. Eberconazole nitrate–loaded spanlastics: nanocarriers for topical delivery system. Tenside Surfactants Detergents. 2025 Mar 26;62(2):178–99.
  74. Dhiman S, Gupta S, Kashaw SK, Chtita S, Kaya S, Almehizia AA, et al. Discovery of novel pyrrolo[2,3-d] pyrimidine derivatives as anticancer agents: virtual screening and molecular dynamic studies. SAR and QSAR in Environmental Research. 2024 Nov;35(11):993–1025.
  75. Saravanan V, Chagaleti BK, Narayanan PL, Anandan VB, Manoharan H, Anjana GV, et al. Discovery and development of COVID‐19 vaccine from laboratory to clinic. Chem Biol Drug Des. 2024;103(1).
  76. Kunjir S, Pathare P, Sharma S, Malayandi R, Malgave A, Natesan S. Development and Validation of Particle Size Measurement for Mesalamine Nanocrystals Using Dynamic Light Scattering and Microscopic Techniques. BioNanoSci. 2025;15(1).
  77. Aishwarya D, Nikhil P, Natesan S, Velayutham R, Peraman R. Development and validation of high‐performance liquid chromatography‐Orbitrap mass spectrometric method for quantification of NDMA in ranitidine drug products and evaluation of antioxidants as inhibitors of classical nitrosation reaction. Rapid Comm Mass Spectrometry.
  78. Sonule B, Mehetre N, Kumar L. Determination of resveratrol in nanoformulations using UV-spectroscopy: forced degradation and drug entrapment. Tenside Surfactants Detergents. 2024 Jul 26;61(4):358–65.
  79. Palacharla VRC, Nirogi R, Kumar N, Nandakumar K. Determination of Intrinsic Clearance and Fraction Unbound in Human Liver Microsomes and In Vitro-In Vivo Extrapolation of Human Hepatic Clearance for Marketed Central Nervous System Drugs. Eur J Drug Metab Pharmacokinet. 2025 Mar;50(2):119–35.
  80. Das T, Kumar P, Kumar S, Mal S, Kumar S, Rajana VK, et al. Design, Synthesis, and Biological Studies of C-5-Substituted Diazenyl Derivatives of Uracil as Potent and Selective Antileishmanial Agents Targeting Uridine Biosynthesis Pathway Enzymes. ACS Infect Dis. 2024 Dec 13;10(12):4314–26.
  81. Choudhary A, Pandey R, Rathod D, Sumalatha S, Murti K, Ravichandiran V, et al. Dehydrozingerone ameliorates arsenic-induced reproductive toxicity in male Wistar rats. J Mol Histol. 2024 Dec;55(6):1131–45.
  82. Chakraborty B, Santra A, Tah D, Goswami K, Jana A, Girigoswami A, et al. Decoding the interaction of an imidazo-pyrimidine derivative with serum proteins: Spectroscopic, computational and structure-activity relationship analysis. Biophysical Chemistry. 2025 Jul;322:107435.
  83. Kumar S, Kumar BH, Nayak R, Pandey S, Kumar N, Pai KSR. Computational screening and molecular dynamics of natural compounds targeting the SH2 domain of STAT3: a multitarget approach using network pharmacology. Mol Divers. 2025
  84. Gumudavelli SV, Shelke A, Priya P, Chauhan R, Dhingra S. Comparative efficacy and safety of tigecycline vs colistin for Carbapenem-resistant Enterobacteriaceae (CRE) infections in cancer patients. Clinical Epidemiology and Global Health. 2025 May;33:101996.
  85. Nikhil P, Aishwarya D, Dhingra S, Pandey K, Ravichandiran V, Peraman R. Comparative analysis of plasma affinity depletion methods: Impact on protein composition and phosphopeptide abundance in human plasma. Electrophoresis. 2024 Oct;45(19–20):1860–73.
  86. Kumari A, Siddiqui NA, Kumari S, Murti K, Kumar R, Pandey K, et al. Combination Therapy for Post-Kala-Azar Dermal Leishmaniasis: A Literature Review of Current Evidence. Indian Journal of Dermatology. 2024 Sep;69(5):396–405.
  87. Choudhary A, Pandey R, Padhy D, Rathod D, Murti K, Dave V, et al. Changes in Energy Dynamics in Arsenic Exposure basedNeurotoxicity: A Comprehensive Review. CMC. 2025 Jul 4;32(24):5008–23.
  88. Dashawant A, Khadke R, Shete A, Gaikwad V. CDSCO alerts: A retrospective dosage form – Wise analysis of quality control alerts issued to pharmaceutical companies from 2018 to 2023. Regulatory Toxicology and Pharmacology. 2025 Feb;156: 105775.
  89. Vollset SE, Ababneh HS, Abate YH, Abbafati C, Abbasgholizadeh R, Abbasian M, et al. Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021. The Lancet. 2024 May;403(10440):2204–56.
  90. Rajendran K, Chekraverthy BK, Peraman R, Kumar H, Devendran RS, Kaggwa B, et al. Biochemical assessment of spironolactone oral suspension in human plasma using ultra‐performance liquid chromatography‐tandem mass spectrometry: Application toward pharmacokinetic study. Separation Science Plus. 2024.
  91. Obulapuram R, Narapaka PK, Esuru C, Singh M, Dhingra S. Association of GI symptoms with health-related quality of life in cancer patients undergoing chemotherapy: a prospective study. Support Care Cancer. 2025;33(4).
  92. Wankhede H, Penumaka SM, Mandal D, Rojatkar S, Gaikwad V, Patil S. Artesunate-loaded bilosomes with enhanced oral bioavailability: in silico and in vitro study against Leishmania donovani promastigotes and in vivo pharmacokinetic assessment in rats. RSC Pharm. 2025;2(3):541–52.
  93. Mahadik SR, Reddy ART, Choudhary K, Nama L, Jamdade MS, Singh S, et al. Arsenic induced cardiotoxicity: An approach for molecular markers, epigenetic predictors and targets. Environmental Toxicology and Pharmacology. 2024 Oct;111:104558.
  94. Sharma R, Abubakar Md, Bisht P, Rachamalla M, Kumar A, Murti K, et al. Arsenic Exposure and Amyloid Precursor Protein Processing: A Focus on Alzheimer’s Disease. CMP. 2024;17.
  95. Malayandi R, Joseph A, Akbar S, Natesan S, Velayutham R. Application of Mechanistic Pharmacokinetic Model for the Optimization of Metformin Delayed Release Dosage Form for Intestinal Targeting. Ind J Pharm Edu Res. 2024 Jun 21;58(3):991–1001.
  96. Malayandi R, Joseph A, Akbar S, Natesan S, Velayutham R. Application of Mechanistic Pharmacokinetic Model for the Optimization of Metformin Delayed Release Dosage Form for Intestinal Targeting. Ind J Pharm Edu Res. 2024 Jun 21;58(3):991–1001.
  97. Sharma A, Anurag, Kaur J, Kesharwani A, Parihar VK. Antimicrobial Potential of Polyphenols: An Update on Alternative forCombating Antimicrobial Resistance. MC. 2024 Jul;20(6):576–96.
  98. Moktan N, Gajbhiye RL, Sahithi TVVS, Roy DN, Kundu R, Banerjee A. Antibacterial and antibiofilm activities of extract and bioactive compounds from Bergenia ciliata (Haw.) Sternb. flowers against Streptococcus mutans through cell membrane damage. Journal of Ethnopharmacology. 2025 Jan;339:119144.
  99. Naresh P, Roy SD, Pawaskar PV, Lokhande PS, Gajbhiye RL, Peraman R. Analytical quality by design guided white analytical chemistry driven green in the development of LC-ICP-MS method for arsenic speciation analysis in HEK-293 cells. Journal of Chromatography B. 2025 Feb;1252:124474.
  100. Pawar R, Naresh P, Kalva B, Kumar MR, Ravichandiran V, Ramalingam P. Analytical quality by design approach for the development of high‐performance liquid chromatography method for simultaneous analysis of metformin and sitagliptin in the presence of major degradation products. J of Separation Science. 2024. 16];47(5).
  101. Lodha T, Birangal S, Pai A, Prabhu S, Nayak S, Francis T, et al. An in-silico approach for the identification of natural compounds as potential BACE1 inhibitors for the treatment of Alzheimer disease. J Appl Pharm Sci. 2024;292–304.
  102. Naresh P, Kumar PH, Naik VY, Das D, Mahindran M, Parihar VK, et al. Amelioration of Arsenic Toxicity Using Phytoconstituents: Experimental Evidence, Mechanisms, and Strategies. Reviews Env Contamination. 2025. ;263(1).
  103. Das S, Khan R, Banerjee S, Ray S, Ray S. Alterations in Circadian Rhythms, Sleep, and Physical Activity in COVID-19: Mechanisms, Interventions, and Lessons for the Future. Mol Neurobiol. 2024 Dec;61(12):10115–37.
  104. Kumar H, Kumar L, Verma R. Afatinib-A Comprehensive Review Of Analytical Methods Developed in Pharmaceuticals and Biological Matrices. Int J App Pharm. 2024 Jul 7;23–8.
  105. Narapaka PK, Kaduburu S, Obulapuram R, Singh M, Murti K. A systematic literature review and meta-analysis of randomized control trials on the influence of shared decision-making as intervention on patients’ satisfaction among mental healthcare. J Public Health (Berl) [Internet]. 2024 Oct 16 [cited 2025 Jul 16];
  106. Rohith Chandra K, Naresh P, Kotesh K, Sirisha K, Kumar GT, Peraman R, et al. A reliable liquid chromatography-quadrupole time-of-flight mass spectrometry method for quantitation of teriflunomide, a metabolite of leflunomide in human plasma of rheumatoid arthritis patients. Analytical Chemistry Letters. 2024 Nov;14(6):862–80.
  107. Malgave A, Malayandi R, Joseph A, Akbar S, Gaikwad V. A Novel Process for Improving the Drug Loading of Highly Water-Soluble High-Dose Drug in FDM 3D Printed Tablets. IJDDT. 2024 Jun 24;14(02):737–43.
  108. Malgave A, Malayandi R, Joseph A, Akbar S, Gaikwad V. A Novel Process for Improving the Drug Loading of Highly Water-Soluble High-Dose Drug in FDM 3D Printed Tablets. IJDDT. 2024 Jun 24;14(02):737–43.
  109. Chakraborty A, Rajana VK, Saritha C, Srivastava A, Mandal D, Das N. A new Eosin Y-based ‘turnon’ fluorescent sensor for ratiometric sensing of toxic mercury ion (Hg2+) offering unaided eye detection and its antibacterial activity. Journal of Hazardous Materials. 2024 May; 470:134207.
  110. Bhargav E, Mohammed N, Singh UN, Ramalingam P, Challa RR, Vallamkonda B, et al. A central composite design-based targeted quercetin nanoliposomal formulation: Optimization and cytotoxic studies on MCF-7 breast cancer cell lines. Heliyon. 2024 Sep;10(17): e37430.
  111. Bhosale, A., Meenakshi, S., Narapaka, P. K., Richa, C., Kalaiselvan, V., Dhingra, S., Murti, K. (2025). Assessment of patterns and predictors of medical device-related adverse events among oncology patients: a cross-sectional study at a tertiary care hospital. Expert Review of Medical Devices, 22(5), 477–487.
  112. Chakraborty B, Santra A, Tah D, Goswami K, Jana A, Girigoswami A, et al. Decoding the interaction of an imidazo-pyrimidine derivative with serum proteins: Spectroscopic, computational and structure-activity relationship analysis. Biophysical Chemistry. 2025 July 1;322:107435.

Year 2023

  1. Abdalla Abdelaziz MA, Nelson VK, Kumarasamy M, Peraman R. Anticancer effect of polyphenolic acid enriched fractions from Grewia bracteata Roth on tumor cells and their p53 gene independent ROS mediated apoptosis in colon cancer cells. Toxicon. 2023 Sep;233:107243..
  2. Agni S, Jose J, Ugare SR, Kumar L, Khot KB. Design, characterization, and evaluation of novel mucoadhesive nasal inserts for the treatment of hypertension. Tenside Surfactants Detergents. 2023 Nov 27;60(6):599–610.
  3. Ahmad R, Oli AN, Etando A, Sharma P, Sinha S, Chowdhury K, et al. Lactic acid bacteria fermented foods: Impact on immune system and consequences over type 2 diabetes mellitus. J App Pharm Sci [Internet]. 2023 [cited 2024 Oct 28]; Available from: https://japsonline.com/abstract.php?article_id=3964&sts=2
  4. Amin R, Pandey R, Vaishali K, Acharya V, Sinha MK, Kumar N. Therapeutic Approaches for the Treatment of Interstitial Lung Disease:An Exploratory Review on Molecular Mechanisms. MRMC. 2024 Apr;24(6):618–33.
  5. Bg PK, Mehrotra S, Marques SM, Kumar L, Verma R. 3D printing in personalized medicines: A focus on applications of the technology. Materials Today Communications. 2023 Jun;35:105875.
  6. Bharati S, Gaikwad V, Chellampillai B. Investigation of a Quantitative Bioanalytical HPLC Method for the Assessment of Famotidine in Pre-clinical Samples: Application for Pharmacokinetic Studies. Analytical Chemistry Letters. 2023 Mar 4;13(2):202–12.
  7. Bharati S, Gaikwad V, Chellampillai B. Bioanalytical method development and Validation for determination of efonidipine hydrochloride ethanolate in rat plasma by high-performance liquid chromatography: applications for pharmacokinetic study. Analytical Chemistry Letters. 2023 Jul 4;13(4):394–402.
  8. Bharati S, Gaikwad V, Pawar A, Chellampillai B. Investigation of a biopolymer-based pH-responsive and sustained release raft-gel-forming tablet of famotidine: In-vitro, ex-vivo, bioavailability and anti-ulcer evaluation in New Zealand albino rabbit. Journal of Drug Delivery Science and Technology. 2023 Sep;86:104649.
  9. Bhargav E, Koteshwara KB, Padmanabha Reddy Y, Sowmya C, Ramalingam P. Development of Curcumin nanophytosomes surface functionalized with Chondroitin sulfate-A for treating k1 Plasmodium falciparum drug-resistant malaria. Journal of Drug Delivery Science and Technology. 2023 Sep;87:104788.
  10. Bhaskaran NA, Jitta SR, Salwa, Kumar L, Sharma P, Kulkarni OP, et al. Folic acid-chitosan functionalized polymeric nanocarriers to treat colon cancer. International Journal of Biological Macromolecules. 2023 Dec;253:127142.
  11. Chandra Mouli HM, Vinod A, Kumari S, Tiwari AK, Kathiravan MK, Ravichandiran V, et al. Deuterated driven new chemical entities: An optimistic way to improve therapeutic efficacy. Bioorganic Chemistry. 2023 Jun;135:106490.
  12. Das A, Dey S, Yadav RN, Dutta P, Dhiman S, Boruah PJ, et al. Unleashing naphthopyranopyrimidine’s anticancer potential: a deep eutectic solvent (DES) study. New J Chem. 2024;48(17):7566–78.
  13. Das T, Das S, Kumar P, C.A. B, Mandal D. Coal waste-derived synthesis of yellow oxidized graphene quantum dots with highly specific superoxide dismutase activity: characterization, kinetics, and biological studies. Nanoscale. 2023;15(44):17861–78.
  14. Dessai AA, Kantak MN, DCruz CEM, Kumar L, Bhide PJ, Shirodkar RK. Formulation and Characterization of Nanoparticulate Drug Carrier System for Lacidipine. ASSAY and Drug Development Technologies. 2023 Oct 1;21(7):309–24.
  15. Dhake PR, Kumbhar ST, Gaikwad VL. Biowaiver based on biopharmaceutics classification system: Considerations and requirements. Pharmaceutical Science Advances. 2024 Dec;2:100020.
  16. Dutta BJ, Rakshe PS, Maurya N, Chib S, Singh S. Unlocking the therapeutic potential of natural stilbene: Exploring pterostilbene as a powerful ally against aging and cognitive decline. Ageing Research Reviews. 2023 Dec;92:102125.
  17. Dutta S, Singhal S, Shah R, Charan J, Dhingra S, Haque M. Daridorexant as a novel pharmacotherapeutic approach in insomnia: a systematic review and meta-analysis. Expert Opinion on Drug Safety. 2023 Dec 2;22(12):1237–51.
  18. Fathima A, Bagang N, Kumar N, Dastidar SG, Shenoy S. Role of SIRT1 in Potentially Toxic Trace Elements (Lead, Fluoride, Aluminum and Cadmium) Associated Neurodevelopmental Toxicity. Biol Trace Elem Res [Internet]. 2024 Feb 28 [cited 2024 Oct 22]; Available from: https://link.springer.com/10.1007/s12011-024-04116-5
  19. Gajbhiye R, Sarma SS, Kumar D, Singh S. The treasure trove of the genus Carex: A phytochemical and pharmacological review. Health Sciences Review. 2024 Mar;10:100151.
  20. Gardner WM, Razo C, McHugh TA, Hagins H, Vilchis-Tella VM, Hennessy C, et al. Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021. The Lancet Haematology. 2023 Sep;10(9):e713–34.
  21. Goswami K, Chakraborty A, Sinha S, Jana A. Recent Advances in the Palladium‐Catalyzed Synthesis of Unnatural Tryptophans. Eur J Org Chem. 2024 Jan 12;e202301028.
  22. Guha P, Dutta S, Murti K, Charan JK, Pandey K, Ravichandiran V, et al. The integration of omics: A promising approach to personalized tuberculosis treatment. Medicine in Omics. 2024 Dec;12:100033.
  23. Jitta SR, Chauhan A, Vaz V, Kumar L. Development and Validation of High Performance Liquid Chromatography Method for Quantification of Hesperetin in a Topical Formulation. IJPS [Internet]. 2023 [cited 2024 Oct 21];85(3). Available from: https://www.ijpsonline.com/articles/development-and-validation-of-high-performance-liquid-chromatography-method-for-quantification-of-hesperetin-in-a-topical-formulat-5001.html
  24. Jitta SR, Salwa, Bhaskaran NA, Marques SM, Kumar L, Cheruku SP, et al. Enhanced tissue distribution of ritonavir-loaded nanostructured lipid carriers—recommending its dose reduction. Drug Deliv and Transl Res. 2024 Jan;14(1):116–30.
  25. Kantak MN, Kumar L, Bhide PJ, Shirodkar RK. Oral Gastroretentive Film of Lacidipine for the Treatment of Gastroparesis. ASSAY and Drug Development Technologies. 2023 Apr 1;21(3):97–109.
  26. Kaur R, Kumar R, Chaudhary V, Devi V, Dhir D, Kumari S, et al. Prevalence of HIV infection among visceral leishmaniasis patients in India: A systematic review and meta-analysis. Clinical Epidemiology and Global Health. 2024 Jan;25:101504.
  27. Keni R, Nayak PG, Kumar N, Kishore A, Alnasser SM, Begum F, et al. Sesamol combats diabetogenic effects of atorvastatin through GLUT-4 expression and improved pancreatic viability. 3 Biotech. 2023 Nov;13(11):377.
  28. Kulkarni SB, Gaikwad VL. Common chemistry, manufacturing, and control deficiencies in abbreviated new drug applications assessed by the US Food and drug administration: Hurdle to access cost-effective medicines. Journal of Pharmacological and Toxicological Methods. 2023 Sep;123:107295.
  29. Kumar P, Kumar P, Shrivastava A, Dar MA, Lokhande KB, Singh N, et al. Immunoinformatics-based multi-epitope containing fused polypeptide vaccine design against visceral leishmaniasis with high immunogenicity and TLR binding. International Journal of Biological Macromolecules. 2023 Dec;253:127567.
  30. Kumar S, Chhabra V, Mehra M, K S, Kumar B H, Shenoy S, et al. The fluorosis conundrum: bridging the gap between science and public health. Toxicology Mechanisms and Methods. 2024 Feb 12;34(2):214–35.
  31. Kumar S, Chhabra V, Shenoy S, Daksh R, Ravichandiran V, Swamy RS, et al. Role of Flavonoids in Modulation of Mitochondria Dynamics duringOxidative Stress. MRMC. 2024 May;24(9):908–19.
  32. Kumar S, Shenoy S, Swamy RS, Ravichandiran V, Kumar N. Fluoride-Induced Mitochondrial Dysfunction and Approaches for Its Intervention. Biol Trace Elem Res. 2024 Mar;202(3):835–49.
  33. Kumari K, Vishwakarma VK, Kumar K, Mridha AR, Arava SK, Dhingra S, et al. Effect of Benidipine Alone and in Combination With Bosentan and Sildenafil in Amelioration of Pulmonary Arterial Hypertension in Experimental Model in Rats. Journal of Cardiovascular Pharmacology. 2024 Apr;83(4):330–9.
  34. Kumbhar S, Khairate R, Bhatia M, Choudhari P, Gaikwad V. Evaluation of curcumin-loaded chitosan nanoparticles for wound healing activity. ADMET DMPK [Internet]. 2023 Aug 25 [cited 2024 Oct 22]; Available from: https://pub.iapchem.org/ojs/index.php/admet/article/view/1897
  35. Ledesma JR, Ma J, Zhang M, Basting AVL, Chu HT, Vongpradith A, et al. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Infectious Diseases. 2024 Jul;24(7):698–725.
  36. Malarvannan M, Kumar KV, Reddy YP, Nikhil P, Aishwarya D, Ravichandiran V, et al. Assessment of computational approaches in the prediction of spectrogram and chromatogram behaviours of analytes in pharmaceutical analysis: assessment review. Futur J Pharm Sci. 2023 Oct 12;9(1):86.
  37. Malayandi R, Malgave A, Gaikwad V, Peraman R, Aishwarya D, Ravichandiran V. Understanding the influence of thermal cycles on the stability of metformin HCl in presence of Sitagliptin phosphate monohydrate and polyvinyl alcohol. J Therm Anal Calorim. 2023 Dec;148(23):13321–35.
  38. Malli K, Kumar L, Verma R. FELODIPINE-REVIEW OF ANALYTICAL METHODS DEVELOPED FOR PHARMACEUTICAL DOSAGE FORMS AND BIOLOGICAL FLUIDS. Int J App Pharm. 2023 Nov 7;53–9.
  39. Marques SM, Kumar L. Factors affecting the preparation of nanocrystals: characterization, surface modifications and toxicity aspects. Expert Opinion on Drug Delivery. 2023 Jul 3;20(7):871–94.
  40. Marques SM, Salwa, Kumar L. Quality-by-Design-based development of an eco-friendly HPLC method for the estimation of nisoldipine in nanoformulations: Forced degradation studies and in-vitro release studies. Sustainable Chemistry and Pharmacy. 2023 Dec;36:101254.
  41. Meenakshi S, Maharana KC, Nama L, Kumar Vadla U, Dhingra S, Ravichandiran V, et al. Targeting Histone 3 Variants Epigenetic Landscape and InhibitoryImmune Checkpoints: An Option for Paediatric Brain Tumours Therapy. CN. 2024 Jun;22(7):1248–70.
  42. Mehrotra S, Salwa, Bg PK, Bhaskaran NA, Srinivas Reddy J, Kumar L. Nose-to-Brain delivery of antiretroviral drug loaded lipidic nanocarriers to purge HIV reservoirs in CNS: A safer approach. Journal of Drug Delivery Science and Technology. 2023 Sep;87:104833.
  43. Min K, Sahu A, Jeon SH, Tae G. Emerging drug delivery systems with traditional routes – A roadmap to chronic inflammatory diseases. Advanced Drug Delivery Reviews. 2023 Dec;203:115119.
  44. Miriam Marques S, Shirodkar RK, Kumar L. Analytical ‘Quality-by-Design’ paradigm in development of a RP-HPLC method for the estimation of cilnidipine in nanoformulations: Forced degradation studies and mathematical modelling of in-vitro release studies. Microchemical Journal. 2023 Oct;193:109124.
  45. Mishra S, Kumarasamy M. Microfluidics engineering towards personalized oncology—a review. In vitro models. 2023 Jul 13;2(3–4):69–81.
  46. Mudgal R, Singh S. Xanthine Oxidoreductase in the Pathogenesis of Endothelial Dysfunction:An Update. CHYR. 2024 Feb;20(1):10–22.
  47. Myrsing E, Vinod A, Mouli HMC, Ravichandiran V, Jana A. Utilizing Graphene Oxide (GO) Catalysed Cascade in the Synthesis of Tetracyclic Pyrano[3,4‐b]indole Derivatives. Asian J Org Chem. 2023 Jun;12(6):e202300126.
  48. Narapaka PK, Singh M, Ramesh M, Dhingra S. Patient-reported involvement in shared decision-making during medical consultations: a systematic literature review. J Public Health (Berl) [Internet]. 2023 Dec 18 [cited 2024 Oct 22]; Available from: https://link.springer.com/10.1007/s10389-023-02153-3
  49. Natekar RM, DCruz CEM, Kumar L, Bhide PJ, Shirodkar RK. Felodipine-loaded Spanlastics: superior nanocarriers for transdermal delivery. Tenside Surfactants Detergents. 2023 Jul 26;60(4):296–311.
  50. Nema M, Dutta BJ, Singh S. Alpha-Lipoic acid alleviates imidacloprid-induced neuro-behavioral deficits in rats via Nrf2/HO-1 pathway. Toxicology Mechanisms and Methods. 2024 Feb 12;34(2):176–88.
  51. Nikhil K, Kumar VU, Pandey K, Ravichandiran V, Murti K. Development and Validation of Knowledge Attitudes and Practices Questionnaire (Nu-KAPQ): for the assessment of Knowledge, Attitudes, and Practices Associated with Arsenic. Biol Trace Elem Res. 2024 Aug;202(8):3465–74.
  52. Nirmal CR, Rajadas SE, Balasubramanian M, Magdaline D, Chilamakuru NB, Dinesh R, et al. Dodecanoic acid & palmitic acid disarms rifampicin resistance by putatively targeting mycobacterial efflux pump Rv1218c. Indian Journal of Medical Research. 2023;157(2 & 3):192–203.
  53. NITTE (Deemed to be University), NGSM Institute of Pharmaceutical Sciences, Department of Pharmaceutics, Mangalore- 575 018, Karnataka, India, Amin B, Jose J, Kumar L. DESIGN, CHARACTERIZATION AND EVALUATION OF NOVEL MUCOADHESIVE NASAL INSERTS FOR THE TREATMENT OF MIGRAINE. IND DRU. 2023 Oct 28;60(10):32–9.
  54. Padhy D, Sharma S, Singh S. Andrographolide protect against lipopolysacharides induced vascular endothelium dysfunction by abrogation of oxidative stress and chronic inflammation in Sprague–Dawley rats. J Biochem & Molecular Tox. 2024 Jan;38(1):e23632.
  55. Pal B, Kumari S, Kaur M, Wadhwa P, Murti K, Kumar R, et al. Barriers to the effective management and prevention of post kala-azar dermal leishmaniasis (PKDL) in the Indian subcontinent. Medical Journal Armed Forces India. 2023 Sep;79(5):500–5.
  56. Pal S, Yellurkar ML, Das P, Sai Prasanna V, Sarkar S, Gajbhiye RL, et al. A network pharmacology, molecular docking and in vitro investigation of Picrorhiza kurroa extract for the treatment of diabetic nephropathy. Journal of Biomolecular Structure and Dynamics. 2024 Feb 14;1–12.
  57. Pandey R, Sharma S, Sinha KK. Evidence of Antibiotic Resistance and Virulence Factors in Environmental Isolates of Vibrio Species. Antibiotics. 2023 Jun 16;12(6):1062.
  58. Pandey R, Bisht P, Wal P, Murti K, Ravichandiran V, Kumar N. SMAC Mimetics for the Treatment of Lung Carcinoma: PresentDevelopment and Future Prospects. MRMC. 2024 Aug;24(14):1334–52.
  59. Patil RS, Kulkarni SB, Gaikwad VL. Artificial intelligence in pharmaceutical regulatory affairs. Drug Discovery Today. 2023 Sep;28(9):103700.
  60. Pavan G, Kumar M, Dhingra S, Kumar N, V R, Murti K. Exploring antibiotic safety: A prospective observational study from a tertiary care public sector hospital. Clinical Epidemiology and Global Health. 2024 Jul;28:101592.
  61. Pawar R, Naresh P, Kalva B, Kumar MR, Ravichandiran V, Ramalingam P. Analytical quality by design approach for the development of high‐performance liquid chromatography method for simultaneous analysis of metformin and sitagliptin in the presence of major degradation products. J of Separation Science. 2024 Mar;47(5):2300605.
  62. Phalle SP, Choudhari PB, Choudhari SP, Bhagwat DA, Kadam AM, Gaikwad VL. Microwave-assisted grafting of acrylamide on a natural xylan gum for controlled drug delivery. Polym Bull. 2024 Feb;81(3):2583–600.
  63. Ponnala V, Narapaka PK, Garapati P, Vishwas G, Imam A, Dhingra S. Exploring the Association Between Statin Use and the Risk of Pancreatic Cancer: an Updated Meta-analysis of Observational Studies. Curr Pharmacol Rep. 2023 May 25;9(4):167–76.
  64. Prajapat SK, Maharana KCh, Singh S. Mitochondrial dysfunction in the pathogenesis of endothelial dysfunction. Mol Cell Biochem. 2024 Aug;479(8):1999–2016.
  65. Prathap Yadav RS, Vijetha Shenoy B, Kumar N, Kumar GP, Kumar SN. In vivo Acetylcholinesterase activity and Antioxidant property of Cucurbita pepo ethanolic extract in Alzheimer’s disease induced by Aluminium chloride in Sprague Dawley rat model. RJPT. 2023 Mar 31;1065–71.
  66. Rajavardhana T, Koushik MR, Jayakumar C, Ramalingam P, Geethavani M, Kumar MA, et al. Adherence to treatment on a daily-dose regimen for TB. int j tuberc lung dis. 2023 Oct 1;27(10):778–80.
  67. Rajendran K, Chekraverthy BK, Peraman R, Kumar H, Devendran RS, Kaggwa B, et al. Biochemical assessment of spironolactone oral suspension in human plasma using ultra‐performance liquid chromatography‐tandem mass spectrometry: Application toward pharmacokinetic study. Separation Science Plus. 2024 Jan 3;2300174.
  68. Rajput K, Dhiman S, Veni NK, Ravichandiran V, Peraman R. Support Vector Models-Based Quantitative Structure–Retention Relationship (QSRR) in the Development and Validation of RP-HPLC Method for Multi-component Analysis of Anti-diabetic Drugs. Chromatographia. 2024 Jan;87(1):3–16.
  69. Rakshe PS, Dutta BJ, Chib S, Maurya N, Singh S. Unveiling the interplay of AMPK/SIRT1/PGC-1α axis in brain health: Promising targets against aging and NDDs. Ageing Research Reviews. 2024 Apr;96:102255.
  70. Randle RK, Amara VR, Popik W. IFI16 Is Indispensable for Promoting HIF-1α-Mediated APOL1 Expression in Human Podocytes under Hypoxic Conditions. IJMS. 2024 Mar 15;25(6):3324.
  71. Rao PP, Shenoy Belle V, Nayak AG, Kumar N, Rao V, Cheruku SP, et al. Evaluation of the merit of ethanolic extract of Annona reticulata as an anti-cancer agent in human colon cancer cell lines (HCT-116). F1000Res. 2023 Dec 8;12:1571.
  72. Ravuluri JAV, Rao V, Kumar G, Manandhar S, Cheruku SP, Bisht P, et al. Brain-targeted Nano-architectures for Efficient Drug Delivery andSensitization in Glioblastoma. CPD. 2023 Jun;29(22):1775–90.
  73. Safdarian M, Trinka E, Rahimi-Movaghar V, Thomschewski A, Aali A, Abady GG, et al. Global, regional, and national burden of spinal cord injury, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet Neurology. 2023 Nov;22(11):1026–47.
  74. Sahu A, Min K, Jeon SH, Kwon K, Tae G. Self-assembled hemin-conjugated heparin with dual-enzymatic cascade reaction activities for acute kidney injury. Carbohydrate Polymers. 2023 Sep;316:121088.
  75. Sajeeda S., Lalit Kumar, Verma R, Alapati S. METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF CLASS-I ELEMENTAL IMPURITIES IN PROPOFOL EMULSION USING ICP-MS. RJC. 2023;16(04):2085–90.
  76. Salas M, Gossell-Williams M, Yalamanchili P, Dhingra S, Malikova MA, Aimer O, et al. The Use of Biomarkers in Pharmacovigilance: A Systematic Review of the Literature. Biomark Insights. 2023 Jan;18:11772719231164528.
  77. Salwa, Kumar L. Quality-by-design driven analytical method (AQbD) development and validation of HPLC–UV technique to quantify rivastigmine hydrogen tartrate in lipidic nanocarriers: Forced degradation, and assessment of drug content and in vitro release studies. Microchemical Journal. 2023 Oct;193:108944.
  78. Sana, Salwa, Shirodkar RK, Kumar L, Verma R. Enhancement of Solubility and Dissolution Rate Using Tailored Rapidly Dissolving Oral Films Containing Felodipine Solid Dispersion: In Vitro Characterization and Ex Vivo Studies. J Pharm Innov. 2023 Sep;18(3):1241–52.
  79. Saravanan V, Chagaleti BK, Narayanan PL, Anandan VB, Manoharan H, Anjana GV, et al. Discovery and development of COVID ‐19 vaccine from laboratory to clinic. Chem Biol Drug Des. 2024 Jan;103(1):e14383.
  80. Shabil M, Bushi G, Beig MA, Rais MA, Ahmed M, Padhi BK. Cardiovascular Manifestation in Tuberculosis Cases: A Systematic Review and Meta-Analysis. Current Problems in Cardiology. 2023 Jul;48(7):101666.
  81. Shabil M, Kumar VU, Dhingra S, Ravichandiran V, Parihar VK, Kumar N, et al. Current Scenario and Strategies to Tackle Cardiovascular Disease Risk in HIV Geriatrics. Curr Pharmacol Rep. 2023 Sep 5;9(6):523–39.
  82. Shabil M, Murti K, Kumar VU, Kumar R, Kumar N, Dhingra S, et al. Older PLHIV are at Higher Cardiovascular Risk with Poor Quality of Life. CHR. 2023 Dec 29;21(6):354–60.
  83. Shabil M, Satapathy P, Kabir R, Padhi BK, Sah R. Shigellosis in Sweden: A public health concern. Clinical Infection in Practice. 2023 Jan;17:100221.
  84. Sharma R, Abubakar Md, Bisht P, Rachamalla M, Kumar A, Murti K, et al. Arsenic Exposure and Amyloid Precursor Protein Processing: A Focus onAlzheimer’s Disease. CMP. 2024 Jan 2;17:e18761429272806.
  85. Sharma S, Bhattacharya S, Joshi K, Singh S. A shift in focus towards precision oncology, driven by revolutionary nanodiagnostics; revealing mysterious pathways in colorectal carcinogenesis. J Cancer Res Clin Oncol. 2023 Nov;149(17):16157–77.
  86. Shetty M, Shenoy S, Kumar N, Amuthan A, Shenoy G, Devi V, et al. Kadukkai maathirai (Siddha herbal formulation) reverses liver pathology associated with metabolic dysfunction in high fat diet-induced fatty liver disease – a preclinical study. RJPT. 2023 Dec 29;6032–8.
  87. Swain HS, Verma R, Kumar L. IRINOTECAN-REVIEW OF ANALYTICAL METHODS DEVELOPED FOR PHARMACEUTICAL DOSAGE FORMS AND BIOLOGICAL FLUIDS. Int J App Pharm. 2023 Nov 7;1–13.
  88. Swamy R, Kumar N, Shenoy S, Kumar N, Rao V. Effect of naringin on sodium fluoride‑induced neurobehavioral deficits in Wistar rats. Biomed Rep. 2024 Apr 29;20(6):97.
  89. Swamy RS, Kumar N, Shenoy S, Cheruku SP, Rao V, Kumar N, et al. Neuroprotective effect by naringin against fluorosis-induced neurodegeneration in adult Wistar rats. NeuroReport. 2023 Jun 7;34(9):449–56.
  90. Vaseem RS, D’cruz A, Shetty S, – H, Vardhan A, R SS, et al. Transdermal Drug Delivery Systems: A Focused Review of the Physical Methods of Permeation Enhancement. Adv Pharm Bull. 2023 Oct 14;1.
  91. Vibhavari RJA, Rao V, Cheruku SP, Kumar BH, Maity S, Nandakumar K, et al. Enhancing temozolomide antiglioma response by inhibiting O6-methylguanine-DNA methyltransferase with selected phytochemicals: in silico and in vitro approach. 3 Biotech. 2023 Dec;13(12):385.
  92. Vinod A, Mouli HMC, Pal P, Myrsing E, Naik VY, Ghosh H, et al. Sustainable Synthesis of Indole-Substituted Densely Functionalized Pyrrole. J Org Chem. 2024 Feb 2;89(3):1407–16.
  93. Walker KEW, Bankay R, Jankie S, Dhingra S. Pharmacovigilance in the Caribbean Countries: an Overview. Curr Pharmacol Rep. 2023 May 18;9(4):217–27.
  94. Worldwide Antimicrobial Resistance National/International Network Group (WARNING) Collaborators, Sartelli M, Barie PS, Coccolini F, Abbas M, Abbo LM, et al. Ten golden rules for optimal antibiotic use in hospital settings: the WARNING call to action. World J Emerg Surg. 2023 Oct 16;18(1):50.
  95. Horse gram (Macrotyloma uniflorum) a traditional food medicine protects the kidney from the cisplatin-induced nephrotoxicity in albino rats. IJTK [Internet]. 2023 Dec 13

Year 2022

  1. Zou Z, Liu G, Hay SI, Basu S, Belgaumi UI, Dhali A, et al. Time trends in tuberculosis mortality across the BRICS: an age-period-cohort analysis for the GBD 2019. eClinicalMedicine. 2022 Nov;53:101646.
  2. Das SS, Dubey AK, Verma PRP, Singh SK, Singh SK. Therapeutic Potential of Quercetin-Loaded Nanoemulsion against Experimental Visceral Leishmaniasis: In Vitro / Ex Vivo Studies and Mechanistic Insights. Mol Pharmaceutics. 2022 Sept 5;19(9):3367–84.
  3. Avanipully JN, Thekkekkara D, M S, Parihar VK, Manjula SN. The Role of Olfactory System in the Etiogenesis of Parkinson’s Diseases: An Overview. Journal of Pharmacology and Pharmacotherapeutics. 2022 Mar;13(1):31–9.
  4. Kumarasamy M, Tran N, Patarroyo J, Mishra S, Monopoli M, Madarasz E, et al. “The Effects of Silver Nanoparticle Shape on Protein Adsorption and Neural Stem Cell Viability.” ChemistrySelect. 2022 Oct 20;7(39):e202201917.
  5. Tiwari A, G S, Meka S, Varghese B, Vishwakarma G, Adela R. The effect of Nigella sativa on non-alcoholic fatty liver disease: A systematic review and meta-analysis. Human Nutrition & Metabolism. 2022 June;28:200146.
  6. Kumbhar ST, Patil RY, Bhatia MS, Choudhari PB, Gaikwad VL. Synthesis and characterization of chitosan nanoparticles decorated with folate and loaded with dasatinib for targeting folate receptors in cancer cells. OpenNano. 2022 July;7:100043.
  7. Mhaske A, Singh S, Abourehab MAS, Kumar A, Kesharwani P, Shukla R. Recent pharmaceutical engineered trends as theranostics for Japanese encephalitis. Process Biochemistry. 2022 Nov;122:115–27.
  8. Singh S, Gautam U, Manvi FV. Protective Impact of Edaravone Against ZnO NPs-induced Oxidative Stress in the Human Neuroblastoma SH-SY5Y Cell Line. Cell Mol Neurobiol. 2022 May;42(4):1189–210.
  9. Alshammari A, Alharbi M, Albekairi NA, Albekairi TH, Alharbi OO, Yeapuri P, et al. Protective Effect of CP690550 in MPTP-Induced Parkinson’s Like Behavioural, Biochemical and Histological Alterations in Mice. Neurotox Res. 2022 Apr;40(2):564–72.
  10. Bhaskaran NA, Jitta SR, Salwa, Cheruku S, Kumar N, Kumar L. Orally delivered solid lipid nanoparticles of irinotecan coupled with chitosan surface modification to treat colon cancer: Preparation, in-vitro and in-vivo evaluations. International Journal of Biological Macromolecules. 2022 June;211:301–15.
  11. Bandyopadhyay I, Dave S, Rai A, Nampoothiri M, Chamallamudi MR, Kumar N. Oral Semaglutide in the Management of Type 2 DM: Clinical Status andComparative Analysis. CDT. 2022 Feb;23(3):311–27.
  12. Kwon K, Jung J, Sahu A, Tae G. Nanoreactor for cascade reaction between SOD and CAT and its tissue regeneration effect. Journal of Controlled Release. 2022 Apr;344:160–72.
  13. Prasad SR, Kumar P, Mandal S, Mohan A, Chaurasia R, Shrivastava A, et al. Mechanistic insight into the role of mevalonate kinase by a natural fatty acid-mediated killing of Leishmania donovani. Sci Rep. 2022 Sept 30;12(1):16453.
  14. Thamineni R, Peraman R, Chenniah J, Meka G, Munagala AK, Mahalingam VT, et al. Level of adherence to anti‐tubercular treatment among drug‐sensitive tuberculosis patients on a newly introduced daily dose regimen in South India: A cross‐sectional study. Tropical Med Int Health. 2022 Nov;27(11):1013–23.
  15. Devipriya JS, Gupta AK, Pavan G, Dhingra S, Murti K, Ravichandiran V, et al. Knowledge, Attitude, and Practices among HIV/Leishmaniasis Co-Infected Patients in Bihar, India. The American Journal of Tropical Medicine and Hygiene. 2022 Oct 12;107(4):789–95.
  16. Sartelli M, Labricciosa FM, Coccolini F, Coimbra R, Abu-Zidan FM, Ansaloni L, et al. It is time to define an organizational model for the prevention and management of infections along the surgical pathway: a worldwide cross-sectional survey. World J Emerg Surg. 2022 Dec;17(1):17.
  17. Kant V, Kumar P, Ranjan R, Kumar P, Mandal D, Vijayakumar S. In silico screening, molecular dynamic simulations, and in vitro activity of selected natural compounds as an inhibitor of Leishmania donovani 3-mercaptopyruvate sulfurtransferase. Parasitol Res. 2022 July;121(7):2093–109.
  18. Mahatme S, K V, Kumar N, Rao V, Kovela RK, Sinha MK. Impact of high-intensity interval training on cardio-metabolic health outcomes and mitochondrial function in older adults: a review. Medicine and Pharmacy Reports. 2022 Apr 20;95(2):115–30.
  19. Vaishali K., Kumar N, Rao V, Kovela RK, Sinha MK. Exercise and Mitochondrial Function: Importance and Inference-A Mini Review. CMM. 2022 Nov;22(9):755–60.
  20. Barodia K, Cheruku SP, Kanwal A, Menon A, Rajeevan R, Rukade A, et al. Effect of Moringa oleifera leaf extract on exercise and dexamethasone-induced functional impairment in skeletal muscles. Journal of Ayurveda and Integrative Medicine. 2022 Jan;13(1):100503.
  21. Bhattacharya S, Sharma S, Prajapati BG. Development of D-α-Tocopherol polyethylene glycol 1000 succinate fabricated nanostructural lipid carrier of sorafenib tosylate for metastatic colorectal targeting application: Stability, physical characterization, cytotoxicity, and apoptotic studies against SW48 cells PTEN. Front Oncol. 2022 Oct 26;12:990841.
  22. Dar MA, Chauhan R, Murti K, Trivedi V, Dhingra S. Development and Validation of Subjective Financial Distress Questionnaire (SFDQ): A Patient Reported Outcome Measure for Assessment of Financial Toxicity Among Radiation Oncology Patients. Front Oncol. 2022 Feb 2;11:819313.
  23. Vignesh M, Kowmudi G, Anoop K, Ramalingam P, Krishnaveni N. Development and validation of a liquid chromatographic-quadrupole time of flight mass spectrometric method for the assay of telmisartan and hydrochlorothiazide in marketed tablet formulations. J App Pharm Sci [Internet]. 2022 Feb 5 [cited 2025 Nov 13]; Available from: https://www.japsonline.com/abstract.php?article_id=3560&sts=2
  24. Dar MA, Kumar P, Kumar P, Shrivastava A, Dar MA, Chauhan R, et al. Designing of Peptide Based Multi-Epitope Vaccine Construct against Gallbladder Cancer Using Immunoinformatics and Computational Approaches. Vaccines. 2022 Oct 31;10(11):1850.
  25. Ranjan OP, Kumar N, Dave V. Cross-linked Alginate Beads of Montelukast Sodium Coated with Eudragitfor Chronotherapy: Statistical Optimization, In vitro and In vivo Evaluation. CDD. 2022 Dec;19(10):1047–60.
  26. Muthubharathi BC, Ravichandiran V, Balamurugan K. Cronobacter sakazakii Cue for the Attraction and Its Impact on the Immunity of Caenorhabditis elegans. Herbert DR, editor. Infect Immun. 2022 Dec 15;90(12):e00281-22.
  27. Dubb S, Kaur G, Kumari S, Murti K, Pal B. Comprehension and compliance with discharge instructions among pediatric caregivers. Clinical Epidemiology and Global Health. 2022 Sept;17:101137.
  28. Nayak S, Kumar P, Shankar R, Mukhopadhyay AK, Mandal D, Das P. Biomass derived self-assembled DNA-dot hydrogels for enhanced bacterial annihilation. Nanoscale. 2022;14(43):16097–109.
  29. Nayak AG, Aithal PA, Kumar N, Shenoy S, Roche M. Augmented rescue of macroglobulins by supplementation of anti-snake venom with methanolic extract of Andrographis paniculata in Naja naja envenomation. 3 Biotech. 2022 Nov;12(11):310.
  30. Kumar A, Rahman MdS, Ali M, Salaun P, Gourain A, Kumar S, et al. Assessment of disease burden in the arsenic exposed population of Chapar village of Samastipur district, Bihar, India, and related mitigation initiative. Environ Sci Pollut Res. 2022 Apr;29(18):27443–59.
  31. Singh R, Kumar A, Rane JS, Khan R, Tripathi G, Ajay AK, et al. Arylcoumarin perturbs SARS-CoV-2 pathogenesis by targeting the S-protein/ACE2 interaction. Sci Rep. 2022 Oct 11;12(1):17038.
  32. Abdelaziz MAA, Dusthackeer VNA, Peraman R. Anticancer Activity of Grewia obtusa Fruit on HCT- 116, MCF-7, and HeLa Tumour Cells Besides Antitubercular Activity. IJPER. 2022 June 30;56(3):765–71.
  33. Pandey RK, Dikhit MR, Lokhande KB, Pandey K, Das P, Bimal S. An immunoprophylactic evaluation of Ld -ODC derived HLA-A0201 restricted peptides against visceral leishmaniasis. Journal of Biomolecular Structure and Dynamics. 2022 Sept 2;40(13):6086–96.
  34. Pandey RK, Dikhit MR, Lokhande KB, Pandey K, Das P, Bimal S. An immunoprophylactic evaluation of Ld -ODC derived HLA-A0201 restricted peptides against visceral leishmaniasis. Journal of Biomolecular Structure and Dynamics. 2022 Sept 2;40(13):6086–96.
  35. Sodum N, Rao V, Cheruku SP, Kumar G, Sankhe R, Kishore A, et al. Amelioration of high-fat diet (HFD) + CCl4 induced NASH/NAFLD in CF-1 mice by activation of SIRT-1 using cinnamoyl sulfonamide hydroxamate derivatives: in-silico molecular modelling and in-vivo prediction. 3 Biotech. 2022 July;12(7):147.
  36. Singh S, Siva BV, Ravichandiran V. Advanced Glycation End Products: key player of the pathogenesis of atherosclerosis. Glycoconj J. 2022 Aug;39(4):547–63.
  1. Yadav P, Chauhan C, Singh S, Banerjee S, Murti K. β-sitosterol in Various Pathological Conditions: An Update. CBC. 2022 June;18(6):e301221199685.
  2. Sartelli M, Coccolini F, Kluger Y, Agastra E, Abu-Zidan FM, Abbas AES, et al. WSES/GAIS/WSIS/SIS-E/AAST global clinical pathways for patients with skin and soft tissue infections. World J Emerg Surg. 2022 Jan 15;17(1):3.
  3. Choudhary A, Singh S, Ravichandiran V. Toxicity, preparation methods and applications of silver nanoparticles: an update. Toxicology Mechanisms and Methods. 2022 Nov 22;32(9):650–61.
  4. Salas M, Petracek J, Yalamanchili P, Aimer O, Kasthuril D, Dhingra S, et al. The Use of Artificial Intelligence in Pharmacovigilance: A Systematic Review of the Literature. Pharm Med. 2022 Oct;36(5):295–306.
  5. Kumar P, Kumar P, Mandal D, Velayutham R. The emerging role of Deubiquitinases (DUBs) in parasites: A foresight review. Front Cell Infect Microbiol. 2022 Sept 27;12:985178.
  6. Rabiu Abubakar A, Ahmad R, Rowaiye AB, Rahman S, Iskandar K, Dutta S, et al. Targeting Specific Checkpoints in the Management of SARS-CoV-2 Induced Cytokine Storm. Life. 2022 Mar 25;12(4):478.
  7. Padmakar S, Murti K, Pandey K, Kumari S, Kumar R, Siddiqui NA, et al. Suicidal ideation associated with vitiligo – A systematic review of prevalence and assessment. Clinical Epidemiology and Global Health. 2022 Sept;17:101140.
  8. Bisht P, Kumar VU, Pandey R, Velayutham R, Kumar N. Role of PARP Inhibitors in Glioblastoma and Perceiving Challenges as Well as Strategies for Successful Clinical Development. Front Pharmacol. 2022 July 6;13:939570.
  9. Ravichandiran V, Jana A. Recent development of allyl–allyl cross-coupling and its application in natural product synthesis. Org Chem Front. 2023;10(1):267–81.
  10. Chand J, Panda SR, Jain S, Murty USN, Das AM, Kumar GJ, et al. Phytochemistry and polypharmacology of cleome species: A comprehensive Ethnopharmacological review of the medicinal plants. Journal of Ethnopharmacology. 2022 Jan;282:114600.
  11. Baranwal A, Aggarwal P, Rai A, Kumar N. Pharmacological Actions and Underlying Mechanisms of Catechin: A Review. MRMC. 2022 Mar;22(5):821–33.
  12. Sharma A, Kumar P, Dutta S, Kaur RJ, Charan J, Chikara G, et al. Pathophysiological and Genetic Basis of Tenofovir-Induced Acute Renal Dysfunction: Strategies and Recent Developments for Better Clinical Outcomes. Curr Pharmacol Rep. 2022 Aug 30;8(6):427–38.
  13. S FA, Madhu M, Udaya Kumar V, Dhingra S, Kumar N, Singh S, et al. Nutritional Aspects of People Living with HIV (PLHIV) Amidst COVID-19 Pandemic: an Insight. Curr Pharmacol Rep. 2022 Aug 6;8(5):350–64.
  14. Xavier J, Singh S, Kumari P, Ravichandiran V. Neurological repercussions of neonatal nicotine exposure: A review. Intl J of Devlp Neuroscience. 2022 Feb;82(1):3–18.
  15. Meenakshi S, Kumar VU, Dhingra S, Murti K. Nasal vaccine as a booster shot: a viable solution to restrict pandemic? Clin Exp Vaccine Res. 2022;11(2):184.
  16. Sahyadri M, Nadiga APR, Mehdi S, Mruthunjaya K, Nayak PG, Parihar VK, et al. Mitochondria–lysosome crosstalk in GBA1-associated Parkinson’s disease. 3 Biotech. 2022 Sept;12(9):230.
  17. Sharma A, Singh A, Dar MA, Kaur RJ, Charan J, Iskandar K, et al. Menace of antimicrobial resistance in LMICs: Current surveillance practices and control measures to tackle hostility. Journal of Infection and Public Health. 2022 Feb;15(2):172–81.
  18. Kumar P, Kumar P, Singh N, Khajuria S, Patel R, Rajana VK, et al. Limitations of current chemotherapy and future of nanoformulation-based AmB delivery for visceral leishmaniasis—An updated review. Front Bioeng Biotechnol. 2022 Dec 14;10:1016925.
  19. Karun A, Kaur RJ, Charan J, Murti K, Ramesh M, Ravichandiran V, et al. Impact of COVID-19 on Antimicrobial Resistance in Paediatric Population: a Narrative Review. Curr Pharmacol Rep. 2022 June 28;8(5):365–75.
  20. Lingamaiah D, Ns S, Murti K, Singh S, Ravichandiran V, Dhingra S. Emicizumab: an FDA-Approved Monoclonal Antibody in the Treatment of Hemophilia A. Curr Pharmacol Rep. 2022 Apr;8(2):121–9.
  21. Goyal JP, Singh S, Bishnoi R, Bhardwaj P, Kaur RJ, Dhingra S, et al. Efficacy and safety of vitamin D in tuberculosis patients: a systematic review and meta-analysis. Expert Review of Anti-infective Therapy. 2022 July 3;20(7):1049–59.
  22. Singh S, Changkija S, Mudgal R, Ravichandiran V. Bioactive components to inhibit foam cell formation in atherosclerosis. Mol Biol Rep. 2022 Mar;49(3):2487–501.
  23. Singh A, Ramalingam P, Dhingra S, Ravichandiran V, Murti K. Arsenic: a Culpable Element and a Possible Menace for HIV/AIDS Patients. Biol Trace Elem Res. 2022 Dec;200(12):4955–66.
  24. Dubey AK, Kumar P, Mandal D, Ravichandiran V, Singh SK. An introduction to dynamic nucleoporins in Leishmania species: Novel targets for tropical-therapeutics. J Parasit Dis. 2022 Dec;46(4):1176–91.

  Connect with
NIPER HAJIPUR

ADDRESS
NIPER - HAJIPUR
Export Promotions Industrial Park (EPIP),
Industrial Area Hajipur,
Dist: Vaishali 844102,
BIHAR, INDIA.

HOME
About
Academic
Project & Research
Students and Alumni
Tender
Facilities
Contact Us

PRIMARY CONTACT
Tel: 06224 - 277224
info[at]niperhajipur[dot]ac[dot]in

NIPERs
NIPER-Ahmedabad
NIPER-Guwahati
NIPER-Kolkata
NIPER-Hyderabad
NIPER-Mohali
NIPER-Raebareili

DEPARTMENT'S
Department of Biotechnology
Department of Pharmacy practice
Department of Pharmacology and Toxicology
Department of Pharmaceutics
Department of Pharmaceutical Analysis

DoP
Govt. of India (National Portal)
Department of Pharmaceuticals(DoP)

Powered By NIPER HAJIPUR © 2023. All Rights Reserved

Total Visits: 5.4k

Disclaimer | Privacy Policy | Terms & Conditions | Site Help | RTI